Santen Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 0.32% vs -8.07% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 22.79% vs -44.73% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "68,957.00",
          "val2": "68,737.00",
          "chgp": "0.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12,780.00",
          "val2": "12,028.00",
          "chgp": "6.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "738.00",
          "val2": "749.00",
          "chgp": "-1.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7,199.00",
          "val2": "5,863.00",
          "chgp": "22.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "116.90%",
          "val2": "109.60%",
          "chgp": "0.73%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -2.79% vs -0.65% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 4.77% vs 34.27% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "291,624.00",
          "val2": "300,004.00",
          "chgp": "-2.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "63,573.00",
          "val2": "74,179.00",
          "chgp": "-14.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,391.00",
          "val2": "1,083.00",
          "chgp": "28.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3,872.00",
          "val2": "-10,140.00",
          "chgp": "61.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37,552.00",
          "val2": "35,844.00",
          "chgp": "4.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "155.00%",
          "val2": "187.40%",
          "chgp": "-3.24%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY

Jun'26

Jun'25

Change(%)

Net Sales

68,957.00

68,737.00

0.32%

Operating Profit (PBDIT) excl Other Income

12,780.00

12,028.00

6.25%

Interest

738.00

749.00

-1.47%

Exceptional Items

0.00

0.00

Consolidate Net Profit

7,199.00

5,863.00

22.79%

Operating Profit Margin (Excl OI)

116.90%

109.60%

0.73%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2026 is 0.32% vs -8.07% in Jun 2025

Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is 22.79% vs -44.73% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

291,624.00

300,004.00

-2.79%

Operating Profit (PBDIT) excl Other Income

63,573.00

74,179.00

-14.30%

Interest

1,391.00

1,083.00

28.44%

Exceptional Items

-3,872.00

-10,140.00

61.81%

Consolidate Net Profit

37,552.00

35,844.00

4.77%

Operating Profit Margin (Excl OI)

155.00%

187.40%

-3.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is -2.79% vs -0.65% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 4.77% vs 34.27% in Mar 2025

All Annual Results